allogenic stem cell therapy (Recalcine/Pontifical Catholic University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameallogenic stem cell therapy (Recalcine/Pontifical Catholic University)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Follicle stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsWounds and Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryChile

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRecalcine Pharmaceutical Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRecalcine Pharmaceutical Corp Pontificia Universidad Catolica De Chile

Active IndicationsN/A

Inactive IndicationsWounds and Injuries

Other Information

ATC CodeN/A